Volume 21, Number 5—May 2015
Research
Transmission of Hepatitis C Virus among Prisoners, Australia, 2005–2012
Table 1
Characteristic | Infected prisoners/ study cohort, n = 79† | Noninfected prisoners, n = 317 | p value‡ | Infected prisoners excluded, n = 102§ | p value¶ |
---|---|---|---|---|---|
Mean (± SD) age, y | 28 (7.2) | 28 (7.0) | 0.71 | 26 (6.5) | 0.13 |
Median (± SD) time since initiation of injecting, y | 6.5 (6.3) | 7 (6.3) | 0.81 | 7 (6.1) | 0.60 |
Male sex | 49 (62) | 216 (68) | 0.41 | 60 (59) | 0.78 |
Aboriginal and/or Torres Strait Islander | 18 (23) | 58 (18) | 0.44 | 37 (36) | 0.07 |
>10 y of education | 61 (77) | 238 (75) | 0.73 | 84 (82) | 0.50 |
Previously imprisoned | 69 (87) | 215 (68) | 0.001 | 77 (75) | 0.07 |
Ever had a tattoo | 58 (73) | 228 (72) | 0.84 | 74 (73) | 1 |
Ever injected drugs in prison | 26 (33) | 67 (21) | 0.04 | 42 (41) | 0.33 |
Ever shared injecting equipment in prison | 23 (29) | 61 (19) | 0.06 | 37 (36) | 0.43 |
*Data are expressed as no. (%) unless otherwise indicated. HITS-p, Hepatitis C Incidence and Transmission Study in Prisons.
†Study cohort = viremic participants from the HITS-p cohort.
‡2-sided comparison of participants from the study cohort and noninfected participants from the HITS-p cohort.
§102 prisoners were excluded because they were infected with an HCV genotype other than 1 or 3.
¶2-sided comparison of participants from the study cohort and infected participants excluded from the study.
1Additional HITS-p investigators are listed at the end of this article.
Page created: April 20, 2015
Page updated: April 20, 2015
Page reviewed: April 20, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.